CVE-2021-22825 | A CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the security token. Affected Products: AP7xxxx and AP8xxx with NMC2 (V6.9.6 or earlier), AP7xxx and AP8xxx with NMC3 (V1.1.0.3 or earlier), and APDU9xxx with NMC3 (V1.0.0.28 or earlier)
A CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the security token. Affected Products: AP7xxxx and AP8xxx with NMC2 (V6.9.6 or earlier), AP7xxx and AP8xxx with NMC3 (V1.1.0.3 or earlier), and APDU9xxx with NMC3 (V1.0.0.28 or earlier)
Zero-Day & Vulnerability Intelligence Hub
Echtzeit-Tracking mit EPSS Exploit-Wahrscheinlichkeiten, Angriffsvektor-Decodern und KI-Patch-Anleitungen.
📊 Historien-Charts — Criticals-Trend · Vendors · EPSS-Verteilung
| Tier | CVEs | Anteil |
|---|---|---|
| ≥90 % | 750 | 0,2 % |
| ≥50 % | 3.273 | 0,8 % |
| ≥10 % | 22.091 | 5,7 % |
| <10 % | 358.954 | 93,2 % |
CVE-2021-22825 | A CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the security token. Affected Products: AP7xxxx and AP8xxx with NMC2 (V6.9.6 or earlier), AP7xxx and AP8xxx with NMC3 (V1.1.0.3 or earlier), and APDU9xxx with NMC3 (V1.0.0.28 or earlier)
A CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the s